Enguang Yang
0000-0002-9028-8065
Publication & Citation Trends
Most Cited Works
Publications
32 total
SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway PDF
Cited by 10
OpenAlex
Enhanced efficacy of immune checkpoint inhibitors by folate-targeted multifunctional drug through synergistic therapy inducing ferroptosis and immunogenic cell death in bladder cancer PDF
Cited by 8
OpenAlex
A machine learning-based prognostic signature utilizing MSC proteomics for predicting bladder cancer prognosis and treatment response PDF
Cited by 3
OpenAlex
Mesenchymal stem cells in tumor microenvironment: drivers of bladder cancer progression through mitochondrial dynamics and energy production PDF
Cited by 13
OpenAlex
Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer PDF
Cited by 6
OpenAlex
Risk factors of high fluid absorption in patients treated with mini-PCNL: a single-center prospective study
Cited by 5
OpenAlex
Identification of a Novel Mesenchymal Stem Cell–Related Signature for Predicting the Prognosis and Therapeutic Responses of Bladder Cancer PDF
Cited by 3
OpenAlex
CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway
Cited by 15
OpenAlex
Research Topics
Bladder and Urothelial Cancer Treatments
(11)
Kidney Stones and Urolithiasis Treatments
(6)
Urinary and Genital Oncology Studies
(6)
Pediatric Urology and Nephrology Studies
(5)
Epigenetics and DNA Methylation
(4)
Frequent Co-Authors
Affiliations
China University of Mining and Technology
Yang-En University
Lanzhou University Second Hospital
Gansu Provincial Center for Disease Control and Prevention
Lanzhou University